Cargando…

What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension?

The outcome of acupuncture on hypertension treatment is inconclusive. This study aims to evaluate the influence of acupuncture on hypertension, based on findings from mechanistic studies over the course of decades particularly those conducted at the University of California, Irvine. Low-current and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ling, Li, Peng, Tjen-A-Looi, Stephanie Cheeyee, Longhurst, John Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666174/ https://www.ncbi.nlm.nih.gov/pubmed/26628909 http://dx.doi.org/10.1186/s13020-015-0070-9

Ejemplares similares

Understanding the lingering consequences of what we treat and what we do
por: Angus, Derek C
Publicado: (2004)

Repetitive Electroacupuncture Attenuates Cold-Induced Hypertension through Enkephalin in the Rostral Ventral Lateral Medulla
por: Li, Min, et al.
Publicado: (2016)

Long-Lasting Reduction of Blood Pressure by Electroacupuncture in Patients with Hypertension: Randomized Controlled Trial
por: Li, Peng, et al.
Publicado: (2015)

Breast cancer risk perception: what do we know and understand?
por: Hopwood, Penelope
Publicado: (2000)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

P01.24. Central processing by electroacupuncture of vasodepression and bradycardia reflex responses
por: Tjen-A-Looi, S, et al.
Publicado: (2012)

Paraventricular Nucleus Modulates Excitatory Cardiovascular Reflexes during Electroacupuncture
por: Tjen-A-Looi, Stephanie C., et al.
Publicado: (2016)

Modulation of Neurally Mediated Vasodepression and Bradycardia by Electroacupuncture through Opioids in Nucleus Tractus Solitarius
por: Tjen-A-Looi, Stephanie C., et al.
Publicado: (2018)

Vita activa in biotechnology: what we do with fungi and what fungi do with us
por: Weinhold, Martin, et al.
Publicado: (2017)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

The WSES: what do we see in the future?
por: De Simone, Belinda, et al.
Publicado: (2021)

Can we do for other essential medicines what we are doing for the COVID-19 vaccine?
por: Murphy, Adrianna, et al.
Publicado: (2021)

Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010)

Ocular surface inflammation in dry eye disease: What we know and what we do not
por: Vazirani, Jayesh
Publicado: (2018)

Neuroendocrine Mechanisms of Acupuncture in the Treatment of Hypertension
por: Zhou, Wei, et al.
Publicado: (2012)

Early goal-directed therapy: what do we do now?
por: Levy, Mitchell M
Publicado: (2014)

Endotracheal tube leak: What should we do?
por: Gupta, Nishkarsh
Publicado: (2015)

Suicide epidemic in Malawi: what can we do?
por: Banda, Gift Treighcy, et al.
Publicado: (2021)

Allied health growth: what we do not measure we cannot manage
por: Solomon, Daniela, et al.
Publicado: (2015)

Maintenance of physical activity: Do we know what we are talking about?
por: Kahlert, Daniela
Publicado: (2015)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

Is Placebo Acupuncture What It Is Intended to Be?
por: Lundeberg, Thomas, et al.
Publicado: (2011)

Traumatic brain injury and resuscitation with blood products: what should we do?
por: Oh, Bryan C, et al.
Publicado: (2011)

Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?
por: Wells, Robert, et al.
Publicado: (2007)

Colonization and infection of the respiratory tract: What do we know?
por: Robinson, Joan
Publicado: (2004)

Medical students find assessments stressful. Of course….but what do we do about it?
por: LeBlanc, Vicki R.
Publicado: (2014)

Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019 (COVID-19): What do we know and what do we need to learn?
por: Jacobs, Jeffrey P., et al.
Publicado: (2022)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

Doing What We Do, Better: Improving Our Work Through Systematic Program Reporting
por: Koek, Irene, et al.
Publicado: (2018)

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
por: Politis, Marios
Publicado: (2010)

Biostatistics as a Tool for Medical Research: What are we Doing Wrong?
por: Tsiamalou, Paraskevi, et al.
Publicado: (2019)

What do we still need to learn on digitally assessed biomarkers?
por: Acs, Balazs, et al.
Publicado: (2021)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

Unrecognized and Undertreated Vertebral Fractures: What Else We Must Do
por: Rao, Sudhaker D
Publicado: (2023)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

Cardiac amyloidosis and surgery: What do we know about rare diseases?
por: Mestres, Carlos A., et al.
Publicado: (2021)

Mass drug administration for malaria elimination: do we understand the settings well enough?
por: Hetzel, Manuel W., et al.
Publicado: (2018)

Understanding environmental influences on nutrition and physical activity behaviors: where should we look and what should we count?
por: Ball, Kylie, et al.
Publicado: (2006)

What do we understand on the Emittance Growth?
por: Papadopoulou, S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jcflg0fdsa7fe8vm9rqeiuncsm